Sign in to view content

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes From the Randomized RECOVERY Trial

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2019

Charles C. Wykoff, MD, PhD

Diabetic Retinopathy Part I Symposium

Related

Macular Edema as Presenting Feature of Peripheral Exudative Hemorrhagic Chorioretinopathy
Amol D Kulkarni, MD, FASRS
On Demand Cases, Courses, and Papers
2020
Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
Updates from the Field
2022
Utilization, Payments, and Effectiveness of Teleophthalmology for Remote Diabetic Eye Screening in the US
Parisa Emami Naeini, MD, MPH, FASRS
Annual Meeting Talks
2022

Category: Diabetic Retinopathy

See more